TCG Crossover GP II reported a 9.2% stake in ADC Therapeutics ADCT · 11,390,175 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 9.2%
Last report: First report
Shares held: 11,390,175 sh
Class: Common Shares, par value CHF $0.08 per share
Stock: ADC Therapeutics ADCT
Holder: TCG Crossover GP II
Event date: 25/10/27
Filed: 26/02/17

First 5%+ report · 9.2% stake

ADC Therapeutics trades, last 26 weeks

What else happened in ADC Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/27~25/11/26

TCG Crossover GP II's other 5% stake reports

TCG Crossover GP II
5% stakeAlx Oncology Holdings
5% stake
Alx Oncology Holdings
ALXO
4.2% stake
5,655,487 sh
4.2% stake
Filed 08/14
TCG Crossover GP II
5% stakeFirst Tracks Biotherapeutics
5% stake
First Tracks Biotherapeutics
TRAX
8.3% stake
2,895,304 sh
8.3% stake
Filed 08/14
TCG Crossover GP II
5% stakeFulcrum Therapeutics
5% stake
Fulcrum Therapeutics
FULC
0% stake
0 sh
0% stake
Filed 08/14
TCG Crossover GP II
5% stakeLB Pharmaceuticals
5% stake
LB Pharmaceuticals
LBRX
5% stake
1,447,310 sh
5% stake
Filed 08/14
TCG Crossover GP II
5% stakeTango Therapeutics
5% stake
Tango Therapeutics
TNGX
7% stake
10,147,867 sh
7% stake
Filed 08/14